154 related articles for article (PubMed ID: 30392914)
1. SOX10-dependent CMTM7 expression inhibits cell proliferation and tumor growth in gastric carcinoma.
Jin Y; Qin X; Jia G
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):91-99. PubMed ID: 30392914
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of CMTM7 inhibits cell growth and migration in liver cancer.
Huang ZM; Li PL; Yang P; Hou XD; Yang YL; Xu X; Xu F
Kaohsiung J Med Sci; 2019 Jun; 35(6):332-340. PubMed ID: 30903681
[TBL] [Abstract][Full Text] [Related]
3. A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth.
Li H; Li J; Su Y; Fan Y; Guo X; Li L; Su X; Rong R; Ying J; Mo X; Liu K; Zhang Z; Yang F; Jiang G; Wang J; Zhang Y; Ma D; Tao Q; Han W
Oncogene; 2014 Jun; 33(24):3109-18. PubMed ID: 23893243
[TBL] [Abstract][Full Text] [Related]
4. miR-135b-5p promotes gastric cancer progression by targeting CMTM3.
Lu M; Huang Y; Sun W; Li P; Li L; Li L
Int J Oncol; 2018 Feb; 52(2):589-598. PubMed ID: 29345297
[TBL] [Abstract][Full Text] [Related]
5. CMTM7 inhibits breast cancer progression by regulating Wnt/β-catenin signaling.
Chen ZH; Tian Y; Zhou GL; Yue HR; Zhou XJ; Ma HY; Ge J; Wang X; Cao XC; Yu Y
Breast Cancer Res; 2023 Feb; 25(1):22. PubMed ID: 36829181
[TBL] [Abstract][Full Text] [Related]
6. CMTM7 knockdown increases tumorigenicity of human non-small cell lung cancer cells and EGFR-AKT signaling by reducing Rab5 activation.
Liu B; Su Y; Li T; Yuan W; Mo X; Li H; He Q; Ma D; Han W
Oncotarget; 2015 Dec; 6(38):41092-107. PubMed ID: 26528697
[TBL] [Abstract][Full Text] [Related]
7. SOX10, a novel HMG-box-containing tumor suppressor, inhibits growth and metastasis of digestive cancers by suppressing the Wnt/β-catenin pathway.
Tong X; Li L; Li X; Heng L; Zhong L; Su X; Rong R; Hu S; Liu W; Jia B; Liu X; Kou G; Han J; Guo S; Hu Y; Li C; Tao Q; Guo Y
Oncotarget; 2014 Nov; 5(21):10571-83. PubMed ID: 25301735
[TBL] [Abstract][Full Text] [Related]
8. CMTM7 as a novel molecule of ATG14L-Beclin1-VPS34 complex enhances autophagy by Rab5 to regulate tumorigenicity.
Liu B; Lu Y; Zhang T; Yu X; Wang Q; Chi Y; Jin S; Cheng G
Cell Commun Signal; 2021 Jul; 19(1):77. PubMed ID: 34281589
[TBL] [Abstract][Full Text] [Related]
9. Change of CMTM7 expression, a potential tumor suppressor, is associated with poor clinical outcome in human non-small cell lung cancer.
Liu Q; Su Y; Jiang GC; Zhou ZL; Liu BC; Bu L; Yang F; Qiao F; Wang J
Chin Med J (Engl); 2013 Aug; 126(16):3006-12. PubMed ID: 23981602
[TBL] [Abstract][Full Text] [Related]
10. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
[TBL] [Abstract][Full Text] [Related]
11. Systematic investigation of CMTM family genes suggests relevance to glioblastoma pathogenesis and CMTM1 and CMTM3 as priority targets.
Delic S; Thuy A; Schulze M; Proescholdt MA; Dietrich P; Bosserhoff AK; Riemenschneider MJ
Genes Chromosomes Cancer; 2015 Jul; 54(7):433-43. PubMed ID: 25931111
[TBL] [Abstract][Full Text] [Related]
12. Essential role for Cmtm7 in cell-surface phenotype, BCR signaling, survival and Igμ repertoire of splenic B-1a cells.
Liu Z; Liu Y; Li T; Wang P; Mo X; Lv P; Ma D; Han W
Cell Immunol; 2020 Jun; 352():104100. PubMed ID: 32305130
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting the role of Skp2 suppresses cell proliferation and tumorigenesis of human gastric cancer cells via the upregulation of p27kip1.
Wen Y; Wang K; Yang K
Mol Med Rep; 2016 Oct; 14(4):3917-24. PubMed ID: 27572672
[TBL] [Abstract][Full Text] [Related]
14. CMTM3 decreases EGFR expression and EGF-mediated tumorigenicity by promoting Rab5 activity in gastric cancer.
Yuan W; Liu B; Wang X; Li T; Xue H; Mo X; Yang S; Ding S; Han W
Cancer Lett; 2017 Feb; 386():77-86. PubMed ID: 27867015
[TBL] [Abstract][Full Text] [Related]
15. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ
Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164
[TBL] [Abstract][Full Text] [Related]
16. siRNA Targeting of the SNCG Gene Inhibits the Growth of Gastric Carcinoma SGC7901 Cells in vitro and in vivo by Downregulating the Phosphorylation of AKT/ERK.
Fan C; Liu J; Tian J; Zhang Y; Yan M; Zhu C
Cytogenet Genome Res; 2018; 154(4):209-216. PubMed ID: 29902801
[TBL] [Abstract][Full Text] [Related]
17. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.
Zeng B; Shi W; Tan G
BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764
[TBL] [Abstract][Full Text] [Related]
18. CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells.
Hu F; Yuan W; Wang X; Sheng Z; Yuan Y; Qin C; He C; Xu T
Clin Transl Oncol; 2015 Aug; 17(8):632-9. PubMed ID: 25990505
[TBL] [Abstract][Full Text] [Related]
19. Methylation-silencing RCC1 expression is associated with tumorigenesis and depth of invasion in gastric cancer.
Lin YL; Chen HL; Cheng SB; Yeh DC; Huang CC; P'eng FK; Tsai TC; Wu CC; Chen CM
Int J Clin Exp Pathol; 2015; 8(11):14257-69. PubMed ID: 26823742
[TBL] [Abstract][Full Text] [Related]
20. CMTM7 plays key roles in TLR-induced plasma cell differentiation and p38 activation in murine B-1 B cells.
Liu Z; Liu Y; Li T; Wang P; Mo X; Lv P; Ma D; Han W
Eur J Immunol; 2020 Jun; 50(6):809-821. PubMed ID: 32022930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
